The goal of this activity is to ensure that oncology nurses, as members of the interprofessional oncology care team, have the knowledge and skills necessary to apply the standards of care to their practice and health care setting for patients with cancer.

Following this program, participants should be able to:

Overall Learning Objectives
•   Evaluate advances in the management of patients with cancer and key updates in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) and apply appropriate treatment and supportive care strategies to optimize patient education and care. 
•   Review issues related to Cultivating Nursing Resilience during a Pandemic; Patient-Reported Outcomes: Assessment and Interventions to Improve Symptom Management; CAR T-Cell Therapy Update; Keeping up with the Molecular Targets in the Treatment of Advanced Non-Small Cell Lung Cancer; Navigating Treatment Selection for Patients with Advanced Ovarian Cancer; Current Clinical Challenges in Cancer Pain Management; and, A Practical Approach to Building a Survivorship Program.

Cultivating Nursing Resilience During a Pandemic
•   Discuss the concept of resilience and how it relates to the field of nursing.
•   Identify challenges in cultivating nursing resilience during a pandemic.
•   Discuss techniques that will assist in fostering nursing resilience now and in times of future global health crises.

Patient-Reported Outcomes: Assessment and Interventions to Improve Symptom Management
•   Recognize the challenges of symptom management in patients with cancer.
•   Describe what patient-reported outcomes (PROs) and electronic patient-reported outcomes (ePROs) are, and settings in which they may be used.
•   Discuss how PROs and ePROs may affect cancer care delivery, patient health outcomes, and health care utilization and associated costs.

Evolution of CAR T-Cell Therapy
•   Outline the indications for existing CAR T-cell therapies.
•   Discuss supportive care and logistics needed during CAR T-cell therapy administration.
•   Identify key components of educational materials needed for a successful CAR T-cell therapy program.

Keeping up with the Molecular Targets in the Treatment of Advanced Non-Small Cell Lung Cancer
•   Identify the molecular targets for metastatic non-small cell lung cancer (NSCLC).
•   Discuss the recommended targeted agents for metastatic NSCLC.
•   Describe side effects that may occur with targeted therapies.

Navigating Treatment Selection for Patients with Advanced Ovarian Cancer
•   Describe to a patient some of the key factors to consider when selecting among the recommended options for treatment of recurrent/refractory ovarian cancer.
•   Describe considerations when choosing between chemotherapy options versus targeted therapies for treatment of persistent/recurrent disease.
•   Outline for a patient the signs and symptoms associated with recurrent and/or progressive disease versus toxicity from different types of treatment, and explain option for management to improve quality of life.

Current Clinical Challenges in Cancer Pain Management
•   Discuss considerations for prescribing controlled substances during an opioid epidemic.
•   Identify disparities in the prescription of controlled substances and groups that are at risk for inadequate management of cancer pain.
•   Develop methods to reduce disparities and encourage safe prescription of opioids and other controlled substances for the management of cancer pain.

Advancing Survivorship Care through Program Development
•   Describe several different survivorship care models for the long-term follow-up of cancer survivors.
•   Discuss ideas to address special areas of survivorship care including fertility, post allogenic stem cell transplant care, and the transition of survivors of childhood cancer from pediatric to adult survivorship programs.
•   Explain how educational programs for survivors and providers can help promote optimal survivorship care.